|
BMRN | Biomarin Pharmaceutical Inc |
|
|
BMRN | Biomarin Pharmaceutical Inc |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 1.85 |
| Leverage | 22.68% |
| Market Cap | $ 9.9B |
| PE | 36.85 |
| Dividend Yield | 0.00% |
| Profit | $ 269.2m |
| Margin | 8.33% |
BioMarin Pharmaceutical Inc. develops and markets therapies for people with rare diseases and serious and life-threatening medical conditions. The company is headquartered in San Rafael, California.